Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A naturally DNase-free CRISPR-Cas12c enzyme silences gene expression
Carolyn J. Huang, Benjamin A. Adler, Jennifer A. Doudna
Molecular Cell (2022) Vol. 82, Iss. 11, pp. 2148-2160.e4
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing
Benjamin A. Adler, Tomas Hessler, Brady F. Cress, et al.
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 1967-1979
Open Access | Times Cited: 75
The genome editing revolution
John van der Oost, Constantinos Patinios
Trends in biotechnology (2023) Vol. 41, Iss. 3, pp. 396-409
Open Access | Times Cited: 61
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Bashdar Mahmud Hussen, Mohammed Fatih Rasul, Snur Rasool Abdullah, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 51
Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox
Eugene V. Koonin, Jonathan S. Gootenberg, Omar O. Abudayyeh
Biochemistry (2023) Vol. 62, Iss. 24, pp. 3465-3487
Open Access | Times Cited: 48
Type IV-A3 CRISPR-Cas systems drive inter-plasmid conflicts by acquiring spacers in trans
Fabienne Benz, Sarah Camara-Wilpert, Jakob Russel, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 6, pp. 875-886.e9
Closed Access | Times Cited: 17
The miniature CRISPR-Cas12m effector binds DNA to block transcription
Wen Y. Wu, Prarthana Mohanraju, Chunyu Liao, et al.
Molecular Cell (2022) Vol. 82, Iss. 23, pp. 4487-4502.e7
Open Access | Times Cited: 60
The type V effectors for CRISPR/Cas-mediated genome engineering in plants
Ruixiang Zhang, Nan Chai, Taoli Liu, et al.
Biotechnology Advances (2024) Vol. 74, pp. 108382-108382
Closed Access | Times Cited: 8
TracrRNA reprogramming enables direct PAM-independent detection of RNA with diverse DNA-targeting Cas12 nucleases
Chunlei Jiao, Natalia L. Peeck, Jiaqi Yu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
TnpB homologues exapted from transposons are RNA-guided transcription factors
Tanner Wiegand, Florian T. Hoffmann, Matt W.G. Walker, et al.
Nature (2024) Vol. 631, Iss. 8020, pp. 439-448
Closed Access | Times Cited: 7
Widespread CRISPR-derived RNA regulatory elements in CRISPR-Cas systems
Sergey Shmakov, Zachary K. Barth, Kira S. Makarova, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 15, pp. 8150-8168
Open Access | Times Cited: 19
Recent application of CRISPR-Cas12 and OMEGA system for genome editing
Isabel Wen Badon, Yeounsun Oh, Ho‐Joong Kim, et al.
Molecular Therapy (2023) Vol. 32, Iss. 1, pp. 32-43
Open Access | Times Cited: 17
Genome-wide Characterization of Diverse Bacteriophages Enabled by RNA-Binding CRISPRi
Benjamin A. Adler, Muntathar Al-Shimary, Jaymin R. Patel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 16
Innate programmable DNA binding by CRISPR-Cas12m effectors enable efficient base editing
Greta Bigelyte, Brigita Duchovska, Rimantė Žedaveinytė, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 6, pp. 3234-3248
Open Access | Times Cited: 6
CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy
Mingming Qin, Chunhao Deng, Liewei Wen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
CRISPRi-ART enables functional genomics of diverse bacteriophages using RNA-binding dCas13d
Benjamin A. Adler, Muntathar Al-Shimary, Jaymin R. Patel, et al.
Nature Microbiology (2025)
Open Access
Systematic and scalable genome-wide essentiality mapping to identify nonessential genes in phages
Denish Piya, Nicholas Nolan, Madeline L. Moore, et al.
PLoS Biology (2023) Vol. 21, Iss. 12, pp. e3002416-e3002416
Open Access | Times Cited: 13
The CRISPR-Cas system in molecular diagnostics
Rao Song, Zhongyi Chen, Hongtao Xiao, et al.
Clinica Chimica Acta (2024) Vol. 561, pp. 119820-119820
Closed Access | Times Cited: 4
Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system
Bo Zhang, Jinying Lin, Vanja Perčulija, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 20, pp. 11820-11833
Open Access | Times Cited: 18
Recent advances in genome engineering by CRISPR technology
Youngsik Lee, Yeounsun Oh, Seung Hwan Lee
BMB Reports (2024) Vol. 57, Iss. 1, pp. 12-18
Open Access | Times Cited: 3
CRISPR Tools for Engineering Prokaryotic Systems: Recent Advances and New Applications
Diego Alba Burbano, Cholpisit Kiattisewee, Ava V. Karanjia, et al.
Annual Review of Chemical and Biomolecular Engineering (2024) Vol. 15, Iss. 1, pp. 389-430
Closed Access | Times Cited: 3
Unity among the diverse RNA-guided CRISPR-Cas interference mechanisms
Chhandosee Ganguly, Saadi Rostami, Kole Long, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 6, pp. 107295-107295
Open Access | Times Cited: 3
Visualization of Type IV-A1 CRISPR-mediated repression of gene expression and plasmid replication
Mariana Sanchez-Londono, Selina Rust, Rogelio Hernández-Tamayo, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 20, pp. 12592-12603
Open Access | Times Cited: 3
Current therapies for osteoarthritis and prospects of CRISPR-based genome, epigenome, and RNA editing in osteoarthritis treatment
Yuxi Chen, Xiao Luo, Rui Kang, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2023) Vol. 51, Iss. 2, pp. 159-183
Open Access | Times Cited: 7
Development of CRISPR Cas9, spin-off technologies and their application in model construction and potential therapeutic methods of Parkinson’s disease
Jiangbo Qu, Na Liu, Lu Gao, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6
Highly efficient and specific regulation of gene expression using enhanced CRISPR-Cas12f system
Yeounsun Oh, Lee Wha Gwon, Hyomin K. Lee, et al.
Gene Therapy (2024) Vol. 31, Iss. 7-8, pp. 358-365
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top